Company Overview of Cellzome AG
Cellzome AG, a drug discovery company, engages in the discovery, development, and commercialization of kinase-targeted drugs for the treatment of inflammatory diseases. It develops a pipeline of kinase inhibitors targeting inflammatory mediators as oral therapeutics for rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, psoriasis, and asthma. The company’s products include PI3Kã, a dual lipid-protein kinase that acts primarily downstream of G-protein coupled receptors and is a key mediator of directed movement of immune cells towards chemoattractants; PI3Kã/ä, dual kinase inhibitors that work in synergy to affect a number of functions in immune cells; and LRRK2, a leucine-...
Founded in 2000
49 6221 137 57 0
49 6221 137 57 201
Key Executives for Cellzome AG
Co Founder, Chairman of the Board and Chairman of Supervisory Board
Co-Founder and Vice President of Research Operations
Vice President of Administration and Finance
Vice President of Development Projects and Head of UK Site
Compensation as of Fiscal Year 2014.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries